PURPOSE: It has been suggested that cysteine-rich secretory protein 3 (CRISP-3) and beta-microseminoprotein (MSP) are associated with outcome in prostate cancer. We investigated whether these markers are related to biochemical recurrence and whether addition of the markers improves prediction of recurring disease. EXPERIMENTAL DESIGN: Tissue microarrays of radical prostatectomy specimens were analyzed for CRISP-3 and MSP by immunohistochemistry. Associations between marker positivity and postprostatectomy biochemical recurrence [prostate-specific antigen (PSA) >0.2 ng/mL with a confirmatory level] were evaluated by univariate and multivariable Cox proportional hazards regression. Multivariable analyses controlled for preoperative PSA and pathologic stage and grade. RESULTS: Among 945 patients, 224 had recurrence. Median follow-up for survivors was 6.0 years. Patients positive for CRISP-3 had smaller recurrence-free probabilities, whereas MSP-positive patients had larger recurrence-free probabilities. On univariate analysis, the hazard ratio for patients positive versus negative for CRISP-3 was 1.53 (P=0.010) and for MSP was 0.63 (P=0.004). On multivariable analysis, both CRISP-3 (P=0.007) and MSP (P=0.002) were associated with recurrence. The hazard ratio among CRISP-3-positive/MSP-negative patients compared with CRISP-3-negative/MSP-positive patients was 2.38. Adding CRISP-3 to a base model that included PSA and pathologic stage and grade did not enhance the prediction of recurrence, but adding MSP increased the concordance index minimally from 0.778 to 0.781. CONCLUSION: We report evidence that CRISP-3 and MSP are independent predictors of recurrence after radical prostatectomy for localized prostate cancer. However, addition of the markers does not importantly improve the performance of existing predictive models. Further research should aim to elucidate the functions of CRISP-3 and MSP in prostate cancer cells.
PURPOSE: It has been suggested that cysteine-rich secretory protein 3 (CRISP-3) and beta-microseminoprotein (MSP) are associated with outcome in prostate cancer. We investigated whether these markers are related to biochemical recurrence and whether addition of the markers improves prediction of recurring disease. EXPERIMENTAL DESIGN: Tissue microarrays of radical prostatectomy specimens were analyzed for CRISP-3 and MSP by immunohistochemistry. Associations between marker positivity and postprostatectomy biochemical recurrence [prostate-specific antigen (PSA) >0.2 ng/mL with a confirmatory level] were evaluated by univariate and multivariable Cox proportional hazards regression. Multivariable analyses controlled for preoperative PSA and pathologic stage and grade. RESULTS: Among 945 patients, 224 had recurrence. Median follow-up for survivors was 6.0 years. Patients positive for CRISP-3 had smaller recurrence-free probabilities, whereas MSP-positive patients had larger recurrence-free probabilities. On univariate analysis, the hazard ratio for patients positive versus negative for CRISP-3 was 1.53 (P=0.010) and for MSP was 0.63 (P=0.004). On multivariable analysis, both CRISP-3 (P=0.007) and MSP (P=0.002) were associated with recurrence. The hazard ratio among CRISP-3-positive/MSP-negative patients compared with CRISP-3-negative/MSP-positive patients was 2.38. Adding CRISP-3 to a base model that included PSA and pathologic stage and grade did not enhance the prediction of recurrence, but adding MSP increased the concordance index minimally from 0.778 to 0.781. CONCLUSION: We report evidence that CRISP-3 and MSP are independent predictors of recurrence after radical prostatectomy for localized prostate cancer. However, addition of the markers does not importantly improve the performance of existing predictive models. Further research should aim to elucidate the functions of CRISP-3 and MSP in prostate cancer cells.
Authors: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; Eric Klein; Patrick A Kupelian; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Jean de Kernion; Thomas Cangiano; Fritz H Schröder; Mark F Wildhagen; Peter T Scardino; Michael W Kattan Journal: J Clin Oncol Date: 2002-02-15 Impact factor: 44.544
Authors: Lene Udby; Jack B Cowland; Anders H Johnsen; Ole E Sørensen; Niels Borregaard; Lars Kjeldsen Journal: J Immunol Methods Date: 2002-05-01 Impact factor: 2.303
Authors: Lene Udby; Ole E Sørensen; Jesper Pass; Anders H Johnsen; Niels Behrendt; Niels Borregaard; Lars Kjeldsen Journal: Biochemistry Date: 2004-10-12 Impact factor: 3.162
Authors: Hong Lou; Hongchuan Li; Meredith Yeager; Kate Im; Bert Gold; Thomas D Schneider; Joseph F Fraumeni; Stephen J Chanock; Stephen K Anderson; Michael Dean Journal: Hum Genet Date: 2012-06-04 Impact factor: 4.132
Authors: Bhakti R Pathak; Ananya A Breed; Vaishali H Nakhawa; Dhanashree D Jagtap; Smita D Mahale Journal: Asian J Androl Date: 2010-08-02 Impact factor: 3.285
Authors: Hong Lou; Meredith Yeager; Hongchuan Li; Jesus Gonzalez Bosquet; Richard B Hayes; Nick Orr; Kai Yu; Amy Hutchinson; Kevin B Jacobs; Peter Kraft; Sholom Wacholder; Nilanjan Chatterjee; Heather Spencer Feigelson; Michael J Thun; W Ryan Diver; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Jing Ma; J Michael Gaziano; Meir Stampfer; Fredrick R Schumacher; Edward Giovannucci; Geraldine Cancel-Tassin; Olivier Cussenot; Antoine Valeri; Gerald L Andriole; E David Crawford; Stephen K Anderson; Margaret Tucker; Robert N Hoover; Joseph F Fraumeni; Gilles Thomas; David J Hunter; Michael Dean; Stephen J Chanock Journal: Proc Natl Acad Sci U S A Date: 2009-04-21 Impact factor: 11.205
Authors: Barbara Wegiel; Thomas Jiborn; Magnus Abrahamson; Leszek Helczynski; Leo Otterbein; Jenny Liao Persson; Anders Bjartell Journal: PLoS One Date: 2009-11-23 Impact factor: 3.240
Authors: Meredith Yeager; Zuoming Deng; Joseph Boland; Casey Matthews; Jennifer Bacior; Victor Lonsberry; Amy Hutchinson; Laura A Burdett; Liqun Qi; Kevin B Jacobs; Jesus Gonzalez-Bosquet; Sonja I Berndt; Richard B Hayes; Robert N Hoover; Gilles Thomas; David J Hunter; Michael Dean; Stephen J Chanock Journal: Hum Genet Date: 2009-12 Impact factor: 4.132